| For: | Righi E, Londero A, Carnelutti A, Baccarani U, Bassetti M. Impact of new treatment options for hepatitis C virus infection in liver transplantation. World J Gastroenterol 2015; 21(38): 10760-10775 [PMID: 26478668 DOI: 10.3748/wjg.v21.i38.10760] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i38/10760.htm |
| Number | Citing Articles |
| 1 |
Antonio Gasbarrini, Maurizio Pompili, Gian Lodovico Rapaccini, Antonio Grieco, Massimo Siciliano, Maria Assunta Zocco, Cecilia Binda, Francesca Mangiola, Francesca Romana Ponziani. Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C. World Journal of Hepatology 2017; 9(7): 352-367 doi: 10.4254/wjh.v9.i7.352
|
| 2 |
Nicholas A. Meanwell. 2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph. Journal of Medicinal Chemistry 2016; 59(16) doi: 10.1021/acs.jmedchem.6b00915
|
| 3 |
Esteban Sáez‐González, Carmen Vinaixa, Fernando San Juan, Vanesa Hontangas, Salvador Benlloch, Victoria Aguilera, Angel Rubín, María García, Martín Prieto, Rafa López‐Andujar, Marina Berenguer. Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT). Liver International 2018; 38(6) doi: 10.1111/liv.13618
|
| 4 |
José María Moreno-Planas, Juan Ramón Larrubia-Marfil, Juan José Sánchez-Ruano, Julia Morillas-Ariño, Roberto Patón-Arenas, Rosa María Sáiz-Chumillas, Emilia Tébar-Romero, Alfredo Lucendo-Villarín, Pilar Gancedo-Bringas, Mario Solera-Muñoz, María del Mar Vicente-Gutiérrez, Elisa Martínez-Alfaro. Influencia de la puntuación MELD basal en la eficacia del tratamiento de la hepatitis C con sofosbuvir y simeprevir. Enfermedades Infecciosas y Microbiología Clínica 2018; 36(5) doi: 10.1016/j.eimc.2017.05.001
|
| 5 |
José María Moreno-Planas, Juan Ramón Larrubia-Marfil, Juan José Sánchez-Ruano, Julia Morillas-Ariño, Roberto Patón-Arenas, Rosa María Sáiz-Chumillas, Emilia Tébar-Romero, Alfredo Lucendo-Villarín, Pilar Gancedo-Bringas, Mario Solera-Muñoz, María del Mar Vicente-Gutiérrez, Elisa Martínez-Alfaro. Influence of baseline MELD score in the efficacy of treatment of hepatitis C with simeprevir and sofosbuvir. Enfermedades infecciosas y microbiologia clinica (English ed.) 2018; 36(5) doi: 10.1016/j.eimce.2018.03.002
|
| 6 |
Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kiran Kumar Katakam, Kristina Fobian, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz, Christian Gluud. Direct-acting antivirals for chronic hepatitis C. Cochrane Database of Systematic Reviews 2017; 2017(9) doi: 10.1002/14651858.CD012143.pub3
|
| 7 |
M. Alfageme Zubillaga, T. Fontanilla Echeveste, I. Pérez González, A. Royuela Vicente, A.M. Duca, R.M. Ruiz Peralbo, C. González Hernando. ARFI elastography: Changes after direct-acting antiviral treatment in transplanted livers with relapse of hepatitis C virus infection. Radiología (English Edition) 2017; 59(2) doi: 10.1016/j.rxeng.2016.12.004
|
| 8 |
Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kristina Fobian, Kiran Kumar Katakam, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz, Christian Gluud, Janus C Jakobsen. Cochrane Database of Systematic Reviews. 2016; doi: 10.1002/14651858.CD012143
|
| 9 |
Noriaki Orita, Tetsuro Shimakami, Hajime Sunagozaka, Rika Horii, Kouki Nio, Tekeshi Terashima, Noriho Iida, Masaaki Kitahara, Hajime Takatori, Kazunori Kawaguchi, Kazuya Kitamura, Kuniaki Arai, Taro Yamashita, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Shuichi Kaneko. Three renal failure cases successfully treated with ombitasvir/paritaprevir/ritonavir for genotype 1b hepatitis C virus reinfection after liver transplantation. Clinical Journal of Gastroenterology 2019; 12(1) doi: 10.1007/s12328-018-0884-y
|
| 10 |
G. Cholankeril, E. R. Yoo, M. Hu, C. Gadiparthi, M. A. Khan, R. B. Perumpail, C. A. Bonham, A. Ahmed. Rates of liver retransplantation in the United States are declining in the era of direct‐acting antiviral agents. Journal of Viral Hepatitis 2017; 24(12) doi: 10.1111/jvh.12750
|
| 11 |
Ong The Due, Usa Chaikledkaew, Anne Julienne M. Genuino, Abhasnee Sobhonslidsuk, Ammarin Thakkinstian. Systematic Review with Meta-Analysis: Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C Genotypes 5 and 6. BioMed Research International 2019; 2019 doi: 10.1155/2019/2301291
|
| 12 |
Sachin Kumar, Salil V. Deo, Salah E. Altarabsheh, Shannon M. Dunlay, Nagaraju Sarabu, Basar Sareyyupoglu, Yakov Elgudin, Benjamin Medalion, Chantal ElAmm, Mahazarin Ginwalla, Michael Zacharias, Rodolpho Benatti, Guilherme H. Oliveira, Ahmet Kilic, Gregg C. Fonarow, Soon J. Park. Effect of Hepatitis C Positivity on Survival in Adult Patients Undergoing Heart Transplantation (from the United Network for Organ Sharing Database). The American Journal of Cardiology 2016; 118(1) doi: 10.1016/j.amjcard.2016.04.023
|
| 13 |
Y. Li, S. Li, X. Duan, C. Yang, M. Xu, L. Chen. Hepatitis C: from discovery to cure. ISBT Science Series 2018; 13(3) doi: 10.1111/voxs.12417
|
| 14 |
T.C. Wirth, M.P. Manns. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma. Annals of Oncology 2016; 27(8) doi: 10.1093/annonc/mdw219
|
| 15 |
Kristopher P. Croome, Amit K. Mathur, Surakit Pungpapong, David D. Lee, Adyr A. Moss, Charles B. Rosen, Julie K. Heimbach, C. Burcin Taner. Equivalent Outcomes With Retransplantation and Primary Liver Transplantation in the Direct-acting Antiviral Era. Transplantation 2019; 103(6) doi: 10.1097/TP.0000000000002460
|
| 16 |
Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kiran Kumar Katakam, Kristina Fobian, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz, Christian Gluud. Direct-acting antivirals for chronic hepatitis C. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD012143.pub2
|
| 17 |
Buddheera W. M. B. Kumburegama, Andreas T. Kristensen, Goran Bjelakovic, Dimitrinka Nikolova, Mark A. Asante, Milica Bjelakovic, Ronald L. Koretz, Mithuna M. Balakumar, Martin E. Michelsen, Sarah L. Klingenberg, Christian Gluud. Direct-acting antivirals for chronic hepatitis C infection: a protocol for a systematic review of observational studies. Systematic Reviews 2026; 15(1) doi: 10.1186/s13643-026-03078-0
|
| 18 |
Sean M. McConachie, Sheila M. Wilhelm, Pramodini B. Kale-Pradhan. New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvir. Expert Review of Clinical Pharmacology 2016; 9(2) doi: 10.1586/17512433.2016.1129272
|
| 19 |
Alice Tung Wan Song, Rodolphe Sobesky, Carmen Vinaixa, Jérôme Dumortier, Sylvie Radenne, François Durand, Yvon Calmus, Géraldine Rousseau, Marianne Latournerie, Cyrille Feray, Valérie Delvart, Bruno Roche, Stéphanie Haim-Boukobza, Anne-Marie Roque-Afonso, Denis Castaing, Edson Abdala, Luiz Augusto Carneiro D’Albuquerque, Jean-Charles Duclos-Vallée, Marina Berenguer, Didier Samuel. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence. World Journal of Gastroenterology 2016; 22(18): 4547-4558 doi: 10.3748/wjg.v22.i18.4547
|
| 20 |
M. Alfageme Zubillaga, T. Fontanilla Echeveste, I. Pérez González, A. Royuela Vicente, A.M. Duca, R.M. Ruiz Peralbo, C. González Hernando. Elastografía tipo ARFI: modificación tras tratamiento antiviral en el trasplante hepático con recidiva por VHC. Radiología 2017; 59(2) doi: 10.1016/j.rx.2016.12.004
|
| 21 |
Jennifer Berumen, Alan Hemming. Liver Retransplantation. Clinics in Liver Disease 2017; 21(2) doi: 10.1016/j.cld.2016.12.013
|
| 22 |
Muhammad H. Bashir, Javid Fazili, Mohammad F. Madhoun, Rajesh Kanagala, Sixia Chen, Salman Nusrat. Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis. European Journal of Gastroenterology & Hepatology 2018; 30(3) doi: 10.1097/MEG.0000000000001032
|
| 23 |
Julia M. Grottenthaler, Christoph R. Werner, Martina Steurer, Ulrich Spengler, Thomas Berg, Cornelius Engelmann, Heiner Wedemeyer, Thomas von Hahn, Wolfgang Stremmel, Anita Pathil, Ulrich Seybold, Eckart Schott, Usha Blessin, Christoph Sarrazin, Martin-Walter Welker, Ellen Harrer, Stefan Scholten, Clemens Hinterleitner, Ulrich M. Lauer, Nisar P. Malek, Christoph P. Berg, Chen-Hua Liu. Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation. PLOS ONE 2018; 13(6) doi: 10.1371/journal.pone.0197544
|
| 24 |
Kylie Su Mei Yong, Zhisheng Her, Qingfeng Chen. Humanized Mouse Models for the Study of Hepatitis C and Host Interactions. Cells 2019; 8(6) doi: 10.3390/cells8060604
|
| 25 |
Shinya Maekawa, Nobuyuki Enomoto. The “real-world” efficacy and safety of DAAs for the treatment of HCV patients throughout Japan. Journal of Gastroenterology 2018; 53(10) doi: 10.1007/s00535-018-1493-8
|